BME:CLNX
BME:CLNXTelecom

Cellnex Telecom (BME:CLNX): Exploring Valuation After Rising Losses Despite Revenue Growth in Latest Results

Cellnex Telecom (BME:CLNX) just released its latest quarterly results, showing sales gains in both the third quarter and the nine-month period, but also a sharp rise in net losses compared to last year. See our latest analysis for Cellnex Telecom. The share price has been under pressure lately, with a 30-day return of -8.6% and a year-to-date decline of -16.4%, reflecting investor caution after Cellnex Telecom’s growing losses. Over the longer run, the 1-year total shareholder return stands...
BME:MAP
BME:MAPInsurance

A Fresh Look at Mapfre (BME:MAP) Valuation Following Strong Nine-Month 2025 Results

Mapfre (BME:MAP) just released financial results for the nine months ended September 2025, posting net income of €829 million, up from €653.5 million a year earlier. This has drawn attention from investors. See our latest analysis for Mapfre. Mapfre shares have shown impressive momentum, with a 63.4% year-to-date share price return as investors react positively to stronger earnings and a revived growth narrative. The longer-term picture is just as compelling, as evidenced by a five-year total...
BME:SAB
BME:SABBanks

The Bull Case For Banco Sabadell (BME:SAB) Could Change Following Analyst Downgrade After TSB Divestment

Banco Sabadell reported its Q3 2025 results, highlighting a recurrent return on tangible equity of 14.1%, confirmed guidance across all profit and loss lines, announced a second interim dividend payable in December, and outlined plans for an extraordinary dividend from the TSB divestment. An analyst downgrade followed, citing concerns about Sabadell’s growing reliance on the Spanish market after the TSB sale and questioning future revenue diversification. We'll examine how Sabadell's...
BME:ALM
BME:ALMPharmaceuticals

Does Almirall’s Robust Q3 Growth and Reaffirmed Guidance Shift the Earnings Outlook for BME:ALM?

Earlier this week, Almirall announced earnings for the nine months ended September 30, 2025, reporting revenue of €825.6 million, up from €731.2 million a year ago, and net income of €39.1 million compared to €7.2 million the previous year, while also reaffirming guidance for double-digit net sales growth of 10%-13% for the full year 2025. This combination of solid revenue growth and a sharp increase in net income suggests stronger operational performance and confidence in achieving...
BME:SCYR
BME:SCYRConstruction

Sacyr (BME:SCYR) Valuation in Focus After Higher Sales but Lower Net Income in 2025 Results

Sacyr (BME:SCYR) released its earnings for the first nine months of 2025, with both sales and revenue moving up compared to last year. However, net income slipped, giving investors something to weigh regarding recent trends. See our latest analysis for Sacyr. Despite mixed earnings, Sacyr’s total shareholder return over the past year stands out at 31.5%. The share price has trended up 17.4% year-to-date, suggesting that investors see ongoing value, even as recent net profits dipped amid...
BME:GEST
BME:GESTAuto Components

Should Gestamp Automoción's (BME:GEST) Rising Q3 Profit Amid Revenue Decline Affect Investor Strategy?

Gestamp Automoción, S.A. has announced its third quarter 2025 results, reporting net income of €29.9 million, up from €20.9 million a year earlier, despite sales and revenue declines for both the quarter and the first nine months of the year. This outcome highlights the company's ability to improve profitability even as overall revenue and sales figures moved lower compared to the prior year period. We'll explore how Gestamp Automoción's higher quarterly net income amid ongoing revenue...
BME:TRE
BME:TREEnergy Services

Why Técnicas Reunidas (BME:TRE) Is Up 5.1% After Nine-Month Sales and Income Surge

Técnicas Reunidas, S.A. reported earnings for the nine months ended September 30, 2025, with sales rising to €4.60 billion and net income reaching €106.9 million, both up from the same period last year. This earnings report reflects improved business performance and financial health, as the company recorded higher sales, revenue, and net income year-over-year. We'll explore how Técnicas Reunidas' substantial year-on-year sales and income growth may influence its investment narrative and...
BDM:CMO
BDM:CMOBasic Materials

Will Lower Earnings and Sales in 2025 Change Cementos Molins' (BDM:CMO) Investment Narrative?

Cementos Molins reported earnings results on October 30, 2025, announcing that sales for the nine months ended September 30 reached €751.4 million, with net income at €140.6 million, both down from the previous year. This decline in sales and net income stands out as a signal of changing business conditions impacting the company's financial performance this year. With both top- and bottom-line results decreasing, we’ll examine how these latest earnings figures shape Cementos Molins’...
BME:BBVA
BME:BBVABanks

A Look at BBVA (BME:BBVA) Valuation Following New Share Buyback and Q3 Earnings Update

Banco Bilbao Vizcaya Argentaria (BME:BBVA) is in the spotlight after announcing a new share buyback program, which represents an important capital management step for shareholders. This comes shortly after its third-quarter earnings update. See our latest analysis for Banco Bilbao Vizcaya Argentaria. After unveiling the share buyback program and delivering steady third-quarter results, Banco Bilbao Vizcaya Argentaria has seen impressive share price momentum. The stock has soared over 18% in...
BME:CLNX
BME:CLNXTelecom

Did Cellnex Telecom's (BME:CLNX) Latest Earnings Shift Its Profitability Story for Investors?

Cellnex Telecom reported its third quarter and nine-month 2025 earnings, with sales rising to €995 million and €2.94 billion respectively, but shifting to a net loss of €148 million for the quarter and €263 million for the period. While revenues showed modest year-over-year growth, the transition from positive net income to losses may raise questions regarding cost management and profitability amid expansion efforts. We will explore how Cellnex's move from profit to net loss could impact its...
BME:ACX
BME:ACXMetals and Mining

Should Acerinox's (BME:ACX) Q3 Net Income Drop Spur Reassessment of Its Profit Recovery Trajectory?

Acerinox, S.A. announced its financial results for the third quarter and nine months ended September 30, 2025, reporting sales of €1,415 million for Q3 and net income of €25 million, compared to €1,307 million and €48 million, respectively, a year earlier. While sales increased year-on-year for both the quarter and the nine-month period, net income declined sharply, underscoring ongoing margin pressures in a challenging market. We'll examine how the pronounced drop in net income relative to...
BME:GRF
BME:GRFBiotechs

How Investors May Respond To Grifols (BME:GRF) Q3 2025 Earnings and Updated Outlook

On November 4, 2025, Grifols, S.A. held its Q3 2025 earnings call, releasing new details about its recent financial performance and company outlook. This earnings report provides key insights into the company's operations and may influence investor sentiment given its importance as an indicator of business momentum and financial health. Now, we'll explore how the recent Q3 earnings disclosure could impact Grifols' investment narrative and future financial projections. The end of cancer?...
BME:LOG
BME:LOGLogistics

Rising Sales Alongside Lower Profits Might Change The Case For Investing In Logista Integral (BME:LOG)

Logista Integral, S.A. has released its full-year earnings results for the period ended September 30, 2025, reporting sales of €13.54 billion compared to €12.99 billion a year earlier, while net income declined to €281 million from €308 million. Although sales increased, the fall in net income highlights shifting profit dynamics even as top-line growth continues, signaling a complex operating environment for the company. We'll explore how Logista Integral's higher sales but lower net income...
BME:UNI
BME:UNIBanks

Unicaja Banco (BME:UNI) Valuation in Focus After Reporting Strong Profit Growth for Q3 and First Nine Months of 2025

Unicaja Banco (BME:UNI) just shared its latest earnings, revealing higher net income for both the third quarter and first nine months of 2025 compared to last year. This steady profit growth stands out to investors. See our latest analysis for Unicaja Banco. After a surge in net income, Unicaja Banco’s share price has raced ahead with a year-to-date price return of 103.34 percent. Momentum has clearly been building, supported by a stellar 1-year total shareholder return of 143.32 percent...
BME:SAN
BME:SANBanks

Banco Santander (BME:SAN) Is Up 7.7% After Surpassing Earnings and Affirming 2025 Revenue Targets – Has The Bull Case Changed?

Banco Santander recently reported its financial results for the first nine months of 2025, highlighting net income of €10.34 billion and improved earnings per share compared to a year ago, alongside reaffirmed confidence in achieving its full-year revenue targets of €62 billion with anticipated fee income growth. The bank also completed several fixed-income offerings totaling $2.8 billion, announcing a broad consortium of underwriters, which reflects continued demand for its debt securities...
BME:ELE
BME:ELEElectric Utilities

How Investors May Respond To Endesa (BME:ELE) Lifting Net Income Outlook for 2025

On October 29, 2025, Endesa, S.A. confirmed its full-year 2025 earnings guidance, stating it expects net income to reach the upper end of its previously forecast range. This update signals strengthened management confidence in Endesa's financial outlook and operational progress against its strategic targets for the year. Let's examine how Endesa's raised earnings guidance shapes expectations for its long-term profitability and growth outlook. Trump's oil boom is here - pipelines are primed...
BME:SCYR
BME:SCYRConstruction

Is Higher Revenue but Lower Profit at Sacyr (BME:SCYR) Signaling Margin Pressures Ahead?

On November 6, 2025, Sacyr, S.A. announced its earnings results for the first nine months of the year, reporting increased sales of €3,411.81 million and revenue of €3,667.78 million compared to the same period in 2024, though net income declined to €62.25 million from €74.01 million. While Sacyr’s overall business activity expanded, the reduction in net income highlights potential cost pressures or margin challenges despite higher turnover. Given the recent increase in revenue alongside a...
BME:BBVA
BME:BBVABanks

How Does BBVA's (BME:BBVA) Net Income Growth Reflect Its Profitability Ambitions?

Banco Bilbao Vizcaya Argentaria reported its third quarter and nine-month 2025 results, highlighting net interest income of €6.64 billion for the quarter and €19.25 billion for the year to date, along with net income of €2.53 billion and €7.98 billion respectively. While quarterly net income saw a slight year-over-year decline, the year-to-date figures reflect growth in both net interest income and profitability compared to the prior period. We'll explore how BBVA's year-to-date net income...
BME:MEL
BME:MELHospitality

Is Resilient Earnings Growth Shifting the Investment Case for Meliá Hotels International (BME:MEL)?

Meliá Hotels International recently reported its financial results for the third quarter and nine months ended September 30, 2025, posting increases in sales, revenue, and net income compared to the previous year. An interesting insight from the results is that the company achieved higher net income over the nine-month period despite ongoing pressures related to operating costs and regional exposure. We'll explore how Meliá's ability to deliver steady earnings growth impacts its overall...
BME:PSG
BME:PSGCommercial Services

How Investors May Respond To Prosegur (BME:PSG) Surpassing Nine-Month Net Income and Sales Marks

Prosegur Compañía de Seguridad, S.A. reported earnings results for the nine months ended September 30, 2025, with sales of €3.67 billion and net income of €82 million, both higher than the previous year. This performance highlights a substantial improvement in profitability, with net income widening more than €29 million compared to the same period last year. We'll explore how Prosegur's significant net income increase bolsters its investment narrative and potential for sustained financial...
BME:FAE
BME:FAEPharmaceuticals

The Bull Case For Faes Farma (BME:FAE) Could Change Following Higher Sales But Lower Net Income

Faes Farma, S.A. recently reported its earnings for the nine months ended September 30, 2025, highlighting sales of €440.95 million and revenue of €454 million, both higher than the prior year, while net income decreased to €73.56 million. Despite higher sales and revenue, the company's lower net income reveals a shift in its profit dynamics during this reporting period. We'll explore how the rise in sales alongside a lower net income influences Faes Farma's investment narrative going...
BME:IBE
BME:IBEElectric Utilities

Iberdrola’s Green Hydrogen Deal With IFF Might Change The Case For Investing In Iberdrola (BME:IBE)

IFF recently announced the installation of a nature-based hydrogen production facility at its Benicarló plant in Spain, using renewable electricity supplied by Iberdrola under a 10-year agreement to produce clean hydrogen for fragrance ingredient manufacturing. This partnership represents the fragrance industry's first use of green hydrogen for production processes, directly supporting both companies' decarbonization targets and helping to eliminate 2,000 tons of carbon dioxide emissions...